Document is current
Any future updates will be listed below
-
Authors
Chirindel, Alin
Nicolas, Guillaume P.
Westerbergh, Frida
McDougall, Lisa
Schmid, David E.
Geistlich, Susanne
Tschan, Viviane J.
Busslinger, Sarah D.
Fokkema, Angelique
Aceto, Nicola
Bernhardt, Peter
van der Meulen, Nicholas P.
Müller, Cristina
Wild, Damian https://orcid.org/0000-0002-8135-5350
Schibli, Roger
-
Funding
Funding for this research was provided by:
University of Basel
- License Information
-
More Information
Article History
Received: 16 October 2024
Accepted: 25 November 2024
First Online: 5 December 2024
Declarations
:
: Aproved by the Ethics Committee of Northwest and Central Switzerland (06.11.2023; 2023 − 01868).
: Informed consent was obtained from the patient before the inclusion into the study. The patient gave written informed consend to anonymously use his clinical and imaging data for publication.
: Patent applications on PSMA ligands with albumin-binding entities have been filed by ITM Medical Isotopes GmbH, Germany. CM and RS are listed as co-inventors on the patent application. PB is a co-founder of Theravision AB.
